400 related articles for article (PubMed ID: 26645051)
1. ALTernative Telomere Maintenance and Cancer.
Dilley RL; Greenberg RA
Trends Cancer; 2015 Oct; 1(2):145-156. PubMed ID: 26645051
[TBL] [Abstract][Full Text] [Related]
2. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Sobinoff AP; Pickett HA
Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
4. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
5. Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks.
Zhang JM; Zou L
Cell Biosci; 2020; 10():30. PubMed ID: 32175073
[TBL] [Abstract][Full Text] [Related]
6. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
7. Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
Gao J; Pickett HA
Nat Rev Cancer; 2022 Sep; 22(9):515-532. PubMed ID: 35790854
[TBL] [Abstract][Full Text] [Related]
8. Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.
Hou K; Yu Y; Li D; Zhang Y; Zhang K; Tong J; Yang K; Jia S
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565323
[TBL] [Abstract][Full Text] [Related]
9. Telomere maintenance in sarcomas.
Johnson JE; Broccoli D
Curr Opin Oncol; 2007 Jul; 19(4):377-82. PubMed ID: 17545803
[TBL] [Abstract][Full Text] [Related]
10. The first molecular details of ALT in human tumor cells.
Muntoni A; Reddel RR
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M; Binder H; Arakelyan A
J Biol Chem; 2024 May; 300(6):107392. PubMed ID: 38763334
[TBL] [Abstract][Full Text] [Related]
12. Changes in the Expression of Pre-Replicative Complex Genes in hTERT and ALT Pediatric Brain Tumors.
Idilli AI; Pagani F; Kerschbamer E; Berardinelli F; Bernabé M; Cayuela ML; Piazza S; Poliani PL; Cusanelli E; Mione MC
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32331249
[No Abstract] [Full Text] [Related]
13. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
14. Detection of alternative lengthening of telomeres mechanism on tumor sections.
Claude E; de Lhoneux G; Pierreux CE; Marbaix E; de Ville de Goyet M; Boulanger C; Van Damme A; Brichard B; Decottignies A
Mol Biomed; 2021 Oct; 2(1):32. PubMed ID: 35006465
[TBL] [Abstract][Full Text] [Related]
15. [ALT--alternative lengthening of telomere].
Wu XM; Tang WR; Luo Y
Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
Queisser A; Heeg S; Thaler M; von Werder A; Opitz OG
Cancer Genet; 2013 Nov; 206(11):374-86. PubMed ID: 24331919
[TBL] [Abstract][Full Text] [Related]
17. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
18. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Sung JY; Lim HW; Joung JG; Park WY
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588
[TBL] [Abstract][Full Text] [Related]
20. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]